SHR0410 Injection + Placebo for SHR0410 Injection
Phase 2Terminated 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postsurgical Pain
Conditions
Postsurgical Pain
Trial Timeline
Aug 9, 2022 → May 31, 2023
NCT ID
NCT05394402About SHR0410 Injection + Placebo for SHR0410 Injection
SHR0410 Injection + Placebo for SHR0410 Injection is a phase 2 stage product being developed by Jiangsu Hengrui Medicine for Postsurgical Pain. The current trial status is terminated. This product is registered under clinical trial identifier NCT05394402. Target conditions include Postsurgical Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05394402 | Phase 2 | Terminated |
Competing Products
1 competing product in Postsurgical Pain
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| HR021618 + HR021618 + Placebo | Jiangsu Hengrui Medicine | Phase 2 | 52 |